Study on Fatty liver disease in Unani Medicine
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2024/07/069842
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subjects of all gender, age of 19 to 75 years.
2.Diagnosed fatty liver disease on the basis of USG abdomen within one month or diagnosed during screening.
3.Either subjects with obesity (those who are not taking medication for obesity) or subjects with type-II diabetes mellitus or both.
4.Subjects willing to participate.
1.Pregnancy or lactating mothers.
2.Subjects with hangover sickness.
3.Boozer subjects (alcohol consumption of more than 14 drinks per week (men) and more than 7drinks per week (women)
4.Subjects consuming hypolipidemic and anti- inflammatory drugs.
5.Subjects in any treatment known to affect hepatic function.
6.History of renal diseases, cardiovascular diseases, pulmonary diseases.
7.Subjects with total parenteral nutrition or bedridden subjects.
8.Subjects with protein malnutrition
9.Subjects with type 2 DM on insulin treatment.
10.Subjects with jejunoileal bypass surgery.
11.Patients on the following drugs and toxins - amiodarone, coralgil, tamoxifen, perhexiline maleate, corticosteroids, synthetic estrogens, methotrexate, iv tetracycline, highly active antiretroviral drugs (HAART).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method